Get access

Characterization of four novel molecular changes in the promoter region of the factor VIII gene

Authors

  • C. Nougier,

    Corresponding author
    1. Service d'Hématologie Biologique, HCL, Hôpital Edouard Herriot, Lyon, France
    2. EAM 4174 Hémostase, Inflammation et Sepsis, Université Claude Bernard Lyon 1, Lyon, France
    • Correspondence: Christophe Nougier, Service d'Hématologie Biologique, Pav E, Hôpital Edouard Herriot, 5 Place d'Arsonval, 69437 Lyon Cedex 03, France.

      Tel.: +33 4 72 11 73 78; fax: +33 4 72 11 73 12;

      e-mail: christophe.nougier@chu-lyon.fr

    Search for more papers by this author
  • O. Roualdes,

    1. Service d'Hématologie Biologique, HCL, Hôpital Edouard Herriot, Lyon, France
    2. EAM 4174 Hémostase, Inflammation et Sepsis, Université Claude Bernard Lyon 1, Lyon, France
    Search for more papers by this author
  • M. Fretigny,

    1. Service d'Hématologie Biologique, HCL, Hôpital Edouard Herriot, Lyon, France
    Search for more papers by this author
  • R. d'Oiron,

    1. Centre de Traitement pour Hémophiles, AP-HP Hôpital Bicêtre, Université Paris XI, le Kremlin-Bicêtre, France
    Search for more papers by this author
  • C. Costa,

    1. Département de Génétique, CHU Henri Mondor-AP-HP, Créteil, France
    Search for more papers by this author
  • C. Negrier,

    1. Service d'Hématologie Biologique, HCL, Hôpital Edouard Herriot, Lyon, France
    2. EAM 4174 Hémostase, Inflammation et Sepsis, Université Claude Bernard Lyon 1, Lyon, France
    Search for more papers by this author
  • C. Vinciguerra

    1. Service d'Hématologie Biologique, HCL, Hôpital Edouard Herriot, Lyon, France
    2. EAM 4174 Hémostase, Inflammation et Sepsis, Université Claude Bernard Lyon 1, Lyon, France
    Search for more papers by this author

Summary

Haemophilia A (HA) is an X-linked recessive bleeding disorder, caused by a wide variety of mutations in the factor VIII (F8) gene, leading to deficiency in the activity of coagulation FVIII. These mutations can affect all the F8 exons from the initiation codon to the termination codon, however, only few molecular changes in the promoter region of the F8 gene were reported so far. Here, we describe six nucleotide variations (c.-51G>A, c.-218T>C, c.-219C>T, c.-219delC, c.-221T>A and c.-664G>A) detected in the F8 promoter and their correlation with clinical phenotype of the patients. Potential role of these mutations in HA was also assessed. Causality was demonstrated with transient transfection experiments using luciferase reporter gene plasmids and computational analysis. Two molecular changes (c.-51G>A and c.-664G>A) did not seem to affect the promoter function of the F8 gene whereas c.-218T>C, c.-219C>T, c.-219delC, c.-221T>A mutations had an impact on the F8 promoter function and were responsible for HA. Furthermore, these mutations were associated with resistance to 1-deamino-8-d-argininevasopressin (desmopressin) therapy when they were causative. When molecular variation was detected in F8 promoter, we propose to use prediction software and to verify predictions by reporter gene analysis. If the mutation is causative, it will be probably associated with a lack of therapeutic response to desmopressin and this clinical implication should be considered by clinicians.

Get access to the full text of this article

Ancillary